SCHEMBL21037520

SCHEMBL21037520

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccccc4-c4ccccc4-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.50
ADORA1 P30542 3/20 0.50
ADORA3 P0DMS8 2/20 0.50
ADORA2B P29275 2/20 0.50
TSHR P16473 2/20 0.50
GPR55 Q9Y2T6 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALOX15 P16050 1/20 0.50
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
MAPT P10636 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 2/20 0.42
NTSR1 P30989 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17720962 1.00 ADORA2A (0.50) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL2883216 0.98 L3MBTL1 (0.52) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL27455503 0.98 L3MBTL1 (0.52) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL31290117 0.98 L3MBTL1 (0.52) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL17720965 0.98 L3MBTL1 (0.52) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL24689432 0.98 L3MBTL1 (0.52) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL17720964 0.96 L3MBTL1 (0.54) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL12854006 0.96 L3MBTL1 (0.54) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL24689765 0.96 L3MBTL1 (0.54) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL19762124 0.96 L3MBTL1 (0.54) ADORA2AADORA1ADORA3ADORA2BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11696458-B2 Organic light-emitting device and method of manufacturing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-04 US disclosed
US-11696458-B2 Organic light-emitting device and method of manufacturing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-04 US disclosed
US-20190165292-A1 ORGANIC LIGHT-EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11696458-B2 Organic light-emitting device and method of manufacturing the same EML4, ICMT, SLC39A7 ADORA2A 2869/4885ADORA1 3621/4885ADORA3 2933/4885
US-20190165292-A1 ORGANIC LIGHT-EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME EML4, ICMT, SLC39A7 ADORA2A 2869/4885ADORA1 3621/4885ADORA3 2933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.